J-Valve Transfemoral Pivotal Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 194 participants.

Also called NCT06455787

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 194 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06455787
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada, France, Japan, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06455787. Allocation not applicable; no masking; primary purpose treatment. Start 2024-10-17 (actual); primary completion 2028-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
J-Valve Transfemoral Pivotal Study
Acronym
JOURNEY
Condition
Aortic Valve Regurgitation
Condition
Aortic Valve Disease Mixed
Intervention (Device)
J-Valve Transfemoral (TF) System
Lead sponsor
JC Medical, Inc., an affiliate of Edwards Lifesciences LLC (class: industry)
Collaborator
Minneapolis Heart Institute Foundation (class: other)
Collaborator
Cardiovascular Research Foundation, New York (class: other)

Record details

Record id
cardio:ct-nct06455787
Content hash
25722b7a09c9c35c2c8f2aa3ddfaa6d2d0d679516eddbb16c9568abfaf388f28